Centessa Pharmaceuticals plc (LON:0ACX)
40.45
+0.44 (1.11%)
Inactive · Last trade price on Jun 23, 2026
Centessa Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -250.64 | -197.53 | -235.76 | -151.09 | -216.21 | -381.9 |
Depreciation & Amortization | 0.34 | 0.32 | 0.34 | 0.31 | 0.13 | 0.03 |
Other Amortization | 1.79 | 1.76 | 0.6 | 0.5 | - | - |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 220.45 |
Loss (Gain) From Sale of Investments | 1.09 | -1.8 | - | - | - | - |
Stock-Based Compensation | 33.64 | 30.96 | 33.55 | 29.39 | 24.97 | 14.85 |
Other Operating Activities | 2.34 | 2.51 | 37.05 | -20.63 | -6.78 | 16.43 |
Change in Accounts Payable | 5.41 | 0.05 | -4.59 | -2.72 | 6.35 | 3.8 |
Change in Other Net Operating Assets | -2.77 | -30.08 | 26.75 | -16.11 | -9.01 | -9.83 |
Operating Cash Flow | -208.8 | -193.82 | -142.06 | -160.34 | -200.55 | -136.16 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.37 | -0.37 | -0.03 | -0.17 | -1.14 | -0.19 |
Cash Acquisitions | - | - | - | - | - | 63.44 |
Investment in Securities | -153.07 | -418.16 | 31.3 | -126.84 | - | - |
Other Investing Activities | - | - | - | - | 0.21 | - |
Investing Cash Flow | -153.44 | -418.53 | 31.27 | -127 | -0.93 | 63.26 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 109.34 | - | - | 73.93 |
Long-Term Debt Repaid | - | - | -110.1 | - | - | - |
Net Debt Issued (Repaid) | - | - | -0.76 | - | - | 73.93 |
Issuance of Common Stock | 322.97 | 296.72 | 370.83 | 21.12 | 0.72 | 344.92 |
Repurchase of Common Stock | -4.05 | -4.79 | -5.32 | - | - | - |
Other Financing Activities | -0.01 | -0.4 | - | - | -0.26 | -0.3 |
Financing Cash Flow | 318.91 | 291.53 | 364.75 | 21.12 | 0.46 | 660.15 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 1.25 | -0.45 | 1.23 | 0.62 | -0.42 | 1.9 |
Net Cash Flow | -42.07 | -321.27 | 255.19 | -265.61 | -201.44 | 589.15 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -209.17 | -194.19 | -142.09 | -160.51 | -201.68 | -136.34 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | -1294.59% | - | -2342.20% | - | - |
Free Cash Flow Per Share | -1.49 | -1.43 | -1.24 | -1.67 | -2.16 | -1.81 |
Levered Free Cash Flow | -128.72 | -138.54 | -75.19 | -96.6 | -108.73 | -82.08 |
Unlevered Free Cash Flow | -122.83 | -132.53 | -68.88 | -90.41 | -104.18 | -80.49 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 10.19 | 9.46 | 10.09 | 9.91 | 7.28 | 1.48 |
Cash Income Tax Paid | 1.33 | 1.33 | 0.08 | 2.94 | 1.3 | - |
Change in Working Capital | 2.64 | -30.03 | 22.16 | -18.83 | -2.66 | -6.03 |